|
PTGX Protagonist Therapeutics Inc 1377121 |
| Balance Sheet |
|
Current Assets
|
$613,455,000.00 |
|
Assets
|
$697,459,000.00 |
|
Current Liabilities
|
$34,549,000.00 |
|
Liabilities
|
$41,986,000.00 |
|
Equity
|
$655,473,000.00 |
|
Shares Out
|
64227057.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-48,943,000.00 |
|
Investing Cash Flow
|
$90,892,000.00 |
| Market Analysis |
Market Cap
|
$8,904,439,182.48 |
|
Price
|
$132.00 |
|
BVPS
|
10.21 |
|
PB
|
13.58 |
|
EPS
|
0.06 |
|
PS
|
37.49 |
|
FCF
|
$-49,158,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:17 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:12 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-25 |
-0.69 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-05 |
0.05 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-0.55 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.62 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PTGX documents filed with the SEC.
PTGX Filings
Clear
